The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
| 2 | H01 | Pituitary and hypothalamic hormones and analogues | |
| 3 | H01C | Hypothalamic hormones | |
| 4 | H01CA | Gonadotropin-releasing hormones |
| Code | Title | |
|---|---|---|
| H01CA01 | Gonadorelin | |
| H01CA02 | Nafarelin |
| Active Ingredient | Description | |
|---|---|---|
| Gonadorelin |
Gonadorelin stimulates the synthesis of follicle stimulating hormone and luteinising hormone in the anterior lobe of the pituitary as well as their release. |
|
| Nafarelin |
Nafarelin is a potent agonistic analogue of gonadotrophin releasing hormone (GnRH). Given as a single dose, nafarelin stimulates release of the pituitary gonadotrophins, LH and FSH, with consequent increase of ovarian and testicular steroidogenesis. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| SYNAREL Nasal spray, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
